Pyrroloquinoline quinone promotes human mesenchymal stem cell-derived mitochondria to improve premature ovarian insufficiency in mice through the SIRT1/ATM/p53 pathway.

MLA

Liu, Shengjie, et al. “Pyrroloquinoline Quinone Promotes Human Mesenchymal Stem Cell-Derived Mitochondria to Improve Premature Ovarian Insufficiency in Mice through the SIRT1/ATM/P53 Pathway.” Stem Cell Research & Therapy, vol. 15, no. 1, Apr. 2024, p. 97. EBSCOhost, https://doi.org/10.1186/s13287-024-03705-4.

APA

Liu, S., Wang, Y., Yang, H., Tan, J., Zhang, J., & Zi, D. (2024). Pyrroloquinoline quinone promotes human mesenchymal stem cell-derived mitochondria to improve premature ovarian insufficiency in mice through the SIRT1/ATM/p53 pathway. Stem Cell Research & Therapy, 15(1), 97. https://doi.org/10.1186/s13287-024-03705-4

Chicago

Liu, Shengjie, Yuanmei Wang, Hanlin Yang, Jun Tan, Jingkaiwen Zhang, and Dan Zi. 2024. “Pyrroloquinoline Quinone Promotes Human Mesenchymal Stem Cell-Derived Mitochondria to Improve Premature Ovarian Insufficiency in Mice through the SIRT1/ATM/P53 Pathway.” Stem Cell Research & Therapy 15 (1): 97. doi:10.1186/s13287-024-03705-4.